{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:05:00Z","timestamp":1791317100294,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:00:00Z","timestamp":1468368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/ejhg.2016.85","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T10:27:09Z","timestamp":1468405629000},"page":"1688-1695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Genotype and brain pathology phenotype in children with tuberous sclerosis complex"],"prefix":"10.1038","volume":"24","author":[{"given":"Iris E","family":"Overwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Swenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"van der Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley BM","family":"Hanemaayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Hoogeveen-Westerveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnies M","family":"van Eeghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten H","family":"Lequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans MW","family":"van den Ouweland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri\u00ebtte A","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nellist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claire Y","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"key":"BFejhg201685_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"M Nellist","year":"1993","unstructured":"Nellist M, Janssen B, Brookcarter PT et al: Identification and characterization of the tuberous sclerosis gene on chromosome-16. Cell 1993; 75: 1305\u20131315.","journal-title":"Cell"},{"key":"BFejhg201685_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, deHoogt R, Hermans C et al: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277: 805\u2013808.","journal-title":"Science"},{"key":"BFejhg201685_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ncb847","volume":"4","author":"XS Gao","year":"2002","unstructured":"Gao XS, Zhang Y, Arrazola P et al: Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 2002; 4: 699\u2013704.","journal-title":"Nat Cell Biol"},{"key":"BFejhg201685_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al: Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2013; 381: 817\u2013824.","journal-title":"Lancet"},{"key":"BFejhg201685_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz DN, Belousova E, Sparagana S et al: Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2013; 381: 125\u2013132.","journal-title":"Lancet"},{"key":"BFejhg201685_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au KS, Williams AT, Roach ES et al: Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 2007; 9: 88\u2013100.","journal-title":"Genet Med"},{"key":"BFejhg201685_CR7","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1017\/S0033291715000264","volume":"45","author":"PF Bolton","year":"2015","unstructured":"Bolton PF, Clifford M, Tye C et al: Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study. Psychol Med 2015; 45: 2321\u20132331.","journal-title":"Psychol Med"},{"key":"BFejhg201685_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.spen.2015.10.002","volume":"4","author":"PM Curatolo","year":"2015","unstructured":"Curatolo PM, Moavero R, Roberto D, Graziola F : Genotype\/phenotype correlations in tuberous sclerosis complex. Semin Pediatr Neurol 2015; 4: 259\u2013273.","journal-title":"Semin Pediatr Neurol"},{"key":"BFejhg201685_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN et al: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001; 68: 64\u201380.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201685_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/08830738050200101301","volume":"20","author":"C Doherty","year":"2005","unstructured":"Doherty C, Goh S, Poussaint TY, Erdag N, Thiele EA : Prognostic significance of tuber count and location in tuberous sclerosis complex. J Child Neurol 2005; 20: 837\u2013841.","journal-title":"J Child Neurol"},{"key":"BFejhg201685_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1212\/01.wnl.0000280578.99900.96","volume":"70","author":"FE Jansen","year":"2008","unstructured":"Jansen FE, Braams O, Vincken KL et al: Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology 2008; 70: 908\u2013915.","journal-title":"Neurology"},{"key":"BFejhg201685_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/epi.12680","volume":"55","author":"SV Kothare","year":"2014","unstructured":"Kothare SV, Singh K, Chalifoux JR et al: Severity of manifestations in tuberous sclerosis complex in relation to genotype. Epilepsia 2014; 55: 1025\u20131029.","journal-title":"Epilepsia"},{"key":"BFejhg201685_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","volume":"13","author":"O Sancak","year":"2005","unstructured":"Sancak O, Nellist M, Goedbloed M et al: Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 2005; 13: 731\u2013741.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201685_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ejhg.2011.241","volume":"20","author":"AM van Eeghen","year":"2012","unstructured":"van Eeghen AM, Black ME, Pulsifer MB, Kwiatkowski DJ, Thiele EA : Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur J Hum Genet 2012; 20: 510\u2013515.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201685_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/jmedgenet-2015-103154","volume":"52","author":"HT Wong","year":"2015","unstructured":"Wong HT, McCartney DL, Lewis JC, Sampson JR, Howe CJ, de Vries PJ : Intellectual ability in tuberous sclerosis complex correlates with predicted effects of mutations on TSC1 and TSC2 proteins. J Med Genet 2015; 52: 815\u2013822.","journal-title":"J Med Genet"},{"key":"BFejhg201685_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/humu.21451","volume":"32","author":"M Hoogeveen-Westerveld","year":"2011","unstructured":"Hoogeveen-Westerveld M, Wentink M, van den Heuvel D et al: Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex. Hum Mutat 2011; 32: 424\u2013435.","journal-title":"Hum Mutat"},{"key":"BFejhg201685_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2014.09.014","volume":"9","author":"L Chantranupong","year":"2014","unstructured":"Chantranupong L, Wolfson RL, Orozco JM et al: The sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep 2014; 9: 1\u20138.","journal-title":"Cell Rep"},{"key":"BFejhg201685_CR18","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F : Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013; 8: 2281\u20132308.","journal-title":"Nat Protoc"},{"key":"BFejhg201685_CR19","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1186\/s12881-015-0155-4","volume":"16","author":"M Nellist","year":"2015","unstructured":"Nellist M, Brouwer RWW, Kockx CEM et al: Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations. BMC Med Genet 2015; 16: e10.","journal-title":"BMC Med Genet"},{"key":"BFejhg201685_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","volume":"23","author":"E Nagy","year":"1998","unstructured":"Nagy E, Maquat LE : A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 1998; 23: 198\u2013199.","journal-title":"Trends Biochem Sci"},{"key":"BFejhg201685_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(97)80012-8","volume":"349","author":"PF Bolton","year":"1997","unstructured":"Bolton PF, Griffiths PD : Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 1997; 349: 392\u2013395.","journal-title":"Lancet"},{"key":"BFejhg201685_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/01.wnl.0000345365.92821.86","volume":"72","author":"CJ Chu-Shore","year":"2009","unstructured":"Chu-Shore CJ, Major P, Montenegro M, Thiele E : Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology 2009; 72: 1165\u20131169.","journal-title":"Neurology"},{"key":"BFejhg201685_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1212\/WNL.0b013e3182104347","volume":"76","author":"AL Numis","year":"2011","unstructured":"Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA : Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 2011; 76: 981\u2013987.","journal-title":"Neurology"},{"key":"BFejhg201685_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00381-012-1892-8","volume":"29","author":"C Michelozzi","year":"2013","unstructured":"Michelozzi C, Di Leo G, Galli F et al: Subependymal nodules and giant cell tumours in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation. Child Nerv Syst 2013; 29: 249\u2013254.","journal-title":"Child Nerv Syst"},{"key":"BFejhg201685_CR25","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/dmcn.12523","volume":"56","author":"S Boronat","year":"2014","unstructured":"Boronat S, Caruso P, Thiele EA : Absence of subependymal nodules in patients with tubers suggests possible neuroectodermal mosaicism in tuberous sclerosis complex. Dev Med Child Neurol 2014; 56: 1207\u20131211.","journal-title":"Dev Med Child Neurol"},{"key":"BFejhg201685_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00439-006-0308-9","volume":"121","author":"P Kozlowski","year":"2007","unstructured":"Kozlowski P, Roberts P, Dabora S et al: Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 2007; 121: 389\u2013400.","journal-title":"Hum Genet"},{"key":"BFejhg201685_CR27","doi-asserted-by":"publisher","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","volume":"11","author":"ME Tyburczy","year":"2015","unstructured":"Tyburczy ME, Dies KA, Glass J et al: Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet 2015; 11: e1005637.","journal-title":"PLoS Genet"},{"key":"BFejhg201685_CR28","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1086\/302412","volume":"64","author":"S Verhoef","year":"1999","unstructured":"Verhoef S, Bakker L, Tempelaars AM et al: High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 1999; 64: 1632\u20131637.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201685_CR29","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1177\/0883073807307093","volume":"22","author":"DA Lyczkowski","year":"2007","unstructured":"Lyczkowski DA, Conant KD, Pulsifer MB et al: Intrafamilial phenotypic variability in tuberous sclerosis complex. J Child Neurol 2007; 22: 1348\u20131355.","journal-title":"J Child Neurol"},{"key":"BFejhg201685_CR30","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/WNL.0b013e3181e04325","volume":"74","author":"PB Crino","year":"2010","unstructured":"Crino PB, Aronica E, Baltuch G, Nathanson KL : Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology 2010; 74: 1716\u20131723.","journal-title":"Neurology"},{"key":"BFejhg201685_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.21317","volume":"62","author":"SMI Goorden","year":"2007","unstructured":"Goorden SMI, van Woerden GM, van der Weerd L, Cheadle JP, Elgersma Y : Cognitive deficits in Tsc1(+\/\u2212)mice in the absence of cerebral lesions and seizures. Ann Neurol 2007; 62: 648\u2013655.","journal-title":"Ann Neurol"},{"key":"BFejhg201685_CR32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00234-013-1184-3","volume":"55","author":"AM van Eeghen","year":"2013","unstructured":"van Eeghen AM, Teran LO, Johnson J, Pulsifer MB, Thiele EA, Caruso P : The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines. Neuroradiology 2013; 55: 1007\u20131014.","journal-title":"Neuroradiology"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201685","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:53Z","timestamp":1684430273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,13]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFejhg201685"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2016.85","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,13]]},"assertion":[{"value":"13 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R Swenker reports financial assistance from Novartis. MCY de Wit reports grants from Dutch Epilepsy Foundation, and grants and non-financial support from Novartis outside the submitted work; and the Erasmus MC received honoraria from Novartis for educational lectures presented by the author. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}